APRE
Aprea TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade D from latest DB weights. Momentum 10.4 / Value 55.9
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
10
Value
56
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $3.30
Why
Momentum10 · Δ7d -
Value56 · Δ7d -0.2
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.2.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Lead driver: Value · See fundamentals
Momentum
10
15% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
56
85% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.7
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 10.4 / Value 55.9
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$6.46M
Beta
1.48
Shares Out
12.59M
P/E (TTM) · Derived
-0.3
P/S (TTM)
12.58
P/FCF (TTM) · Derived
-0.44
Rev YoY
-100.0%
EPS YoY
-87.4%
Gross Margin
-324.5%
Op Margin
-4631.1%
Net Debt
-$14.6M
Current Ratio
13.55
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data